TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26 16:02 | 8/4/26 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Aunan Greg D | FL | O | Chief Ac | 1 | S.d | -321 | 16.07 | 0 | -20 | 5 | D | |||||||||||||||
8/5/26 16:11 | 8/3/26 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | Scanlon Jennifer F. | IL | DO | P,CEO | 3 | S.d | -3,641 | 97.10 | 0 | -38 | 266 | D | |||||||||||||||
6/17/26 16:07 | 6/15/26 | NEO | Neogenomics Inc | NV | Health | Biolab | Testing Laboratories | Tetrault Lynn A. | FL | D | 2 | S.d | -119 | 11.20 | 0 | -11 | 98 | D | ||||||||||||||||
6/10/26 17:22 | 6/9/26 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | Pepping Karen K | IL | O | SVP,CAO | 1 | S.d | -71 | 97.74 | 0 | -1 | 8 | D | |||||||||||||||
6/4/26 16:26 | 6/2/26 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | Schjotz Gitte | IL | O | See Rema | 1 | S.m | -2,155 | 98.48 | 0 | -22 | 59 | D | |||||||||||||||
6/1/26 16:05 | 5/28/26 | ULS | Ul Solutions Inc. | DE | Health | Biolab | Testing Laboratories | Uggetti Alberto | IL | O | EVP,CCO | 1 | S | -234 | 99.89 | 0 | -2 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |